ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX), a biopharmaceutical company, is dedicated to in-licensing, developing and commercializing proprietary product candidates. Their key focus is on the treatment of cancer. The Company intends to enhance the performance and commercial potential of existing treatments by addressing issues related with these treatment regimens. For further information, visit the Company’s web site at www.adventrx.com.
- 17 years ago
QualityStocks
ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Featured in NetworkNewsWire Editorial on Soaring Gold Prices and Emerging Producers
LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced its inclusion in a NetworkNewsWire editorial…
-
QualityStocksNewsBreaks – Nicola Mining Inc. (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) Expands Gravel Pit Operations and Completes Cement Ready Mix Plant
Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) together with partner Lower Nicola Site Services Ltd.,…
-
QualityStocksNewsBreaks – FAVO Capital (OTC: FAVO) Appoints Dr. Wael Barsoum as Independent Director
FAVO Capital (OTC: FAVO), a diversified financial company with operations in financial services and real estate,…